The Vaccine Alliance, Gavi and Bavarian Nordic on Wednesday announced an Advance Purchase Agreement to secure 500,000 doses of the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine, which will be supplied to countries in Africa affected by the mpox outbreak. The doses are scheduled for delivery in 2024, according to a press statement issued by
Discover more from HOT SOURCE NEWS
Subscribe to get the latest posts sent to your email.